Heart and Vessels

, Volume 30, Issue 1, pp 28–35 | Cite as

Evaluation of coronary artery disease and cardiac morphology and function in patients with hypertrophic cardiomyopathy, using cardiac computed tomography

  • Satoshi OkayamaEmail author
  • Tsunenari Soeda
  • Rika Kawakami
  • Yasuhiro Takami
  • Satoshi Somekawa
  • Tomoya Ueda
  • Yu Sugawara
  • Takaki Matsumoto
  • Ji Hee Sung
  • Taku Nishida
  • Shiro Uemura
  • Yoshihiko Saito
Original Article


Coronary artery disease and cardiac morphology and function were evaluated in 51 patients with hypertrophic cardiomyopathy (HCM), without typical chest pain, using cardiac computed tomography (CT). This study investigated the prevalence of coronary artery disease, the indicators of obstructive coronary stenosis, and the magnitude of left ventricular (LV) hypertrophy. The patients’ mean coronary artery calcium score was 198.8 ± 312.0 and was positively correlated with the number of coronary risk factors (r = 0.32; P < 0.05). Of the 51 patients with HCM, 42 (82.4 %) had some degree of stenosis and 8 (15.7 %) had obstructive stenosis. Noncalcified and mixed plaques were detected in 14 (27.5 %) and 11 (21.6 %) patients, respectively. Multivariate logistic regression revealed that diabetes was an independent indicator of the presence of obstructive stenosis in HCM patients. Multivariate linear regression revealed that low estimated glomerular filtration rates and high triglyceride concentrations were independent indicators of higher LV mass indexes. In conclusion, cardiac CT revealed that coronary artery disease was common among patients with HCM. The presence of obstructive coronary stenosis and the magnitude of LV hypertrophy were related to the presence of diabetes, triglyceride levels, and estimated glomerular filtration rate.


Hypertrophic cardiomyopathy Coronary artery disease Computed tomography Diabetes 


  1. 1.
    Maron BJ (2002) Hypertrophic cardiomyopathy: a systematic review. JAMA 287:1308–1320PubMedGoogle Scholar
  2. 2.
    Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, McKenna WJ (2000) Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 36:2212–2218PubMedCrossRefGoogle Scholar
  3. 3.
    Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE, Graham KJ, Burton DA, Cecchi F (2000) Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation 102:858–864PubMedCrossRefGoogle Scholar
  4. 4.
    Melacini P, Basso C, Angelini A, Calore C, Bobbo F, Tokajuk B, Bellini N, Smaniotto G, Zucchetto M, Iliceto S, Thiene G, Maron BJ (2010) Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy. Eur Heart J 31:2111–2123PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ (2001) Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 104:2517–2524PubMedCrossRefGoogle Scholar
  6. 6.
    Sorajja P, Ommen SR, Nishimura RA, Gersh BJ, Berger PB, Tajik AJ (2003) Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease. Circulation 108:2342–2348PubMedCrossRefGoogle Scholar
  7. 7.
    Ueda H, Harimoto K, Tomoyama S, Tamaru H, Miyawaki M, Mitsusada N, Yasuga Y, Hiraoka H (2012) Relation of cardiovascular risk factors and angina status to obstructive coronary artery disease according to categorical coronary artery calcium score. Heart Vessels 27:128–134PubMedCrossRefGoogle Scholar
  8. 8.
    Soeda T, Uemura S, Okayama S, Kawakami R, Sugawara Y, Nakagawa H, Matsumoto T, Sung JH, Nishida T, Senoo A, Somekawa S, Takeda Y, Ishigami K, Kawata H, Horii M, Saito Y (2011) Intensive lipid-lowering therapy with rosuvastatin stabilizes lipid-rich coronary plaques. Evaluation using dual-source computed tomography. Circ J 75:2621–2627PubMedCrossRefGoogle Scholar
  9. 9.
    Soeda T, Uemura S, Morikawa Y, Ishigami K, Okayama S, Hee SJ, Nishida T, Onoue K, Somekawa S, Takeda Y, Kawata H, Horii M, Saito Y (2011) Diagnostic accuracy of dual-source computed tomography in the characterization of coronary atherosclerotic plaques: comparison with intravascular optical coherence tomography. Int J Cardiol 148:313–318PubMedCrossRefGoogle Scholar
  10. 10.
    Wu YW, Tadamura E, Kanao S, Yamamuro M, Okayama S, Ozasa N, Toma M, Kimura T, Kita T, Marui A, Komeda M, Togashi K (2008) Left ventricular functional analysis using 64-slice multidetector row computed tomography: comparison with left ventriculography and cardiovascular magnetic resonance. Cardiology 109:135–142PubMedCrossRefGoogle Scholar
  11. 11.
    Hof I, Arbab-Zadeh A, Dong J, Scherr D, Chilukuri K, Calkins H (2008) Validation of a simplified method to determine left atrial volume by computed tomography in patients with atrial fibrillation. Am J Cardiol 102:1567–1570PubMedCrossRefGoogle Scholar
  12. 12.
    Berliner JI, Kino A, Carr JC, Bonow RO, Choudhury L (2012) Cardiac computed tomographic imaging to evaluate myocardial scarring/fibrosis in patients with hypertrophic cardiomyopathy: a comparison with cardiac magnetic resonance imaging. Int J Cardiovasc Imaging 29:191–197PubMedCrossRefGoogle Scholar
  13. 13.
    Ehara S, Matsumoto K, Shirai N, Nakanishi K, Otsuka K, Iguchi T, Hasegawa T, Nakata S, Yoshikawa J, Yoshiyama M (2013) Typical coronary appearance of dilated cardiomyopathy versus left ventricular concentric hypertrophy: coronary volumes measured by multislice computed tomography. Heart Vessels 28:188–198PubMedCrossRefGoogle Scholar
  14. 14.
    Zhao L, Ma X, Delano MC, Jiang T, Zhang C, Liu Y, Zhang Z (2012) Assessment of myocardial fibrosis and coronary arteries in hypertrophic cardiomyopathy using combined arterial and delayed enhanced CT: comparison with MR and coronary angiography. Eur Radiol 23:1034–1043PubMedCrossRefGoogle Scholar
  15. 15.
    Martínez M, Castillo-Moreno JA, Pérez-Milá L, Cano-Vivar P (2010) Value of multidetector computed tomography in patients with chest pain and suspected apical hypertrophic cardiomyopathy. Rev Esp Cardiol 63:612–613PubMedCrossRefGoogle Scholar
  16. 16.
    Chen CC, Chen MT, Lei MH, Hsu YC, Chung SL, Sung YJ (2010) Assessing myocardial bridging and left ventricular configuration by 64-slice computed tomography in patients with apical hypertrophic cardiomyopathy presenting with chest pain. J Comput Assist Tomogr 34:70–74PubMedCrossRefGoogle Scholar
  17. 17.
    Okayama S, Uemura S, Soeda T, Horii M, Saito Y (2010) Role of cardiac computed tomography in planning and evaluating percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. J Cardiovasc Comput Tomogr 4:62–65PubMedCrossRefGoogle Scholar
  18. 18.
    Goldman L, Weinberg M, Weisberg M, Olshen R, Cook EF, Sargent RK, Lamas GA, Dennis C, Wilson C, Deckelbaum L, Fineberg H, Stiratelli R (1982) A computer-derived protocol to aid in the diagnosis of emergency room patients with acute chest pain. N Engl J Med 307:588–596PubMedCrossRefGoogle Scholar
  19. 19.
    Okayama S, Uemura S, Saito Y (2013) Evaluation of epicardial and intra-myocardial fat in a patient with mitochondrial cardiomyopathy. Int J Cardiol 167:e43–e45PubMedCrossRefGoogle Scholar
  20. 20.
    Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ (2003) Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348:295–303PubMedCrossRefGoogle Scholar
  21. 21.
    Wang TJ (2008) New cardiovascular risk factors exist, but are they clinically useful? Eur Heart J 29:441–444PubMedCrossRefGoogle Scholar
  22. 22.
    Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S (2007) Modification of the modification of diet in renal disease (MDRD) study equation for Japan. Am J Kidney Dis 50:927–937PubMedCrossRefGoogle Scholar
  23. 23.
    Lee J (2011) Coronary artery calcium scoring and its impact on the clinical practice in the era of multidetector CT. Int J Cardiovasc Imaging 27(Suppl 1):9–25PubMedCrossRefGoogle Scholar
  24. 24.
    Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe BB (1975) A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 51:5–40PubMedCrossRefGoogle Scholar
  25. 25.
    Cheng VY, Wolak A, Gutstein A, Gransar H, Wong ND, Dey D, Thomson LE, Hayes SW, Friedman JD, Slomka PJ, Berman DS (2010) Low-density lipoprotein and noncalcified coronary plaque composition in patients with newly diagnosed coronary artery disease on computed tomographic angiography. Am J Cardiol 105:761–766PubMedCrossRefGoogle Scholar
  26. 26.
    Gao Y, Lu B, Sun ML, Hou ZH, Yu FF, Cao HL, Chen Y, Yang YJ, Jiang SL, Budoff MJ (2011) Comparison of atherosclerotic plaque by computed tomography angiography in patients with and without diabetes mellitus and with known or suspected coronary artery disease. Am J Cardiol 108:809–813PubMedCrossRefGoogle Scholar
  27. 27.
    Sipola P, Magga J, Husso M, Jääskeläinen P, Peuhkurinen K, Kuusisto J (2011) Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation. Eur Radiol 21:1383–1389PubMedCrossRefGoogle Scholar
  28. 28.
    Sandstede J, Lipke C, Beer M, Hofmann S, Pabst T, Kenn W, Neubauer S, Hahn D (2000) Age- and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging. Eur Radiol 10:438–442PubMedCrossRefGoogle Scholar
  29. 29.
    Maceira AM, Cosín-Sales J, Roughton M, Prasad SK, Pennell DJ (2010) Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 12:65PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Pundziute G, Schuijf JD, Jukema JW, Decramer I, Sarno G, Vanhoenacker PK, Boersma E, Reiber JH, Schalij MJ, Wijns W, Bax JJ (2008) Evaluation of plaque characteristics in acute coronary syndromes: non-invasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis. Eur Heart J 29:2373–2381PubMedCrossRefGoogle Scholar
  31. 31.
    Niakan E, Harati Y, Rolak LA, Comstock JP, Rokey R (1986) Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy. Arch Intern Med 146:2229–2230PubMedCrossRefGoogle Scholar
  32. 32.
    Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ (2000) Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342:1778–1785PubMedCrossRefGoogle Scholar
  33. 33.
    Park M, Hsu CY, Li Y, Mishra RK, Keane M, Rosas SE, Dries D, Xie D, Chen J, He J, Anderson A, Go AS, Shlipak MG (2012) Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol 23:1725–1734PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Schillaci G, Pirro M, Pucci G, Mannarino MR, Gemelli F, Siepi D, Vaudo G, Mannarino E (2006) Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women. Hypertension 47:881–886PubMedCrossRefGoogle Scholar
  35. 35.
    Kawashiri MA, Hayashi K, Konno T, Fujino N, Ino H, Yamagishi M (2013) Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects. Heart Vessels. doi: 10.1007/s00380-013-0391-5 Google Scholar
  36. 36.
    Fujita E, Nakanishi T, Nishizawa T, Hagiwara N, Matsuoka R (2013) Mutations in the cardiac troponin T gene show various prognoses in Japanese patients with hypertrophic cardiomyopathy. Heart Vessels. doi: 10.1007/s00380-013-0332-3 PubMedCentralGoogle Scholar

Copyright information

© Springer Japan 2013

Authors and Affiliations

  • Satoshi Okayama
    • 1
    Email author
  • Tsunenari Soeda
    • 1
  • Rika Kawakami
    • 1
  • Yasuhiro Takami
    • 1
  • Satoshi Somekawa
    • 1
  • Tomoya Ueda
    • 1
  • Yu Sugawara
    • 1
  • Takaki Matsumoto
    • 1
  • Ji Hee Sung
    • 2
  • Taku Nishida
    • 1
  • Shiro Uemura
    • 1
  • Yoshihiko Saito
    • 1
  1. 1.First Department of Internal MedicineNara Medical UniversityNaraJapan
  2. 2.Department of CardiologyYamato-Kashihara HospitalNaraJapan

Personalised recommendations